Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

Creative Commons License

KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., ...Daha Fazla

Transfusion and Apheresis Science, cilt.59, sa.5, 2020 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 59 Sayı: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.transci.2020.102871
  • Dergi Adı: Transfusion and Apheresis Science
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, EMBASE, MEDLINE
  • Anahtar Kelimeler: Autologous stem cell transplantation (ASCT), Convalescent plasma, COVID-19, Lymphoma, SARS-CoV-2
  • Hacettepe Üniversitesi Adresli: Evet

Özet

© 2020 Elsevier LtdAcute respiratory syndrome coronavirus 2 (SARS-CoV-2) first identified in Wuhan, China; and spread all over the world. Reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 usually returns to negative in 20 days post-infection, but prolonged positivity has been reported up to 63 days. A case whose viral shedding lasted 60 days is reported from China. Herein we report a patient with a history of autologous stem cell transplantation (ASCT) for lymphoma whose RT-PCR test remained positive for SARS-CoV-2 for 74 days. The prolonged RT-PCR positivity, despite convalescent plasma infusion, may suggest that the given antibodies may be ineffective in terms of viral clearance. In patients with hematological malignancies or immunosuppression, such as ASCT, may lead to prolonged viral shedding, and strict isolation is warranted for long-term SARS-CoV-2 infection control.